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Brca2 deficiency causes Mre11-dependent degrada-
tion of nascent DNA at stalled forks, leading to cell
lethality. To understand the molecular mechanisms
underlying this process, we isolated Xenopus laevis
Brca2. We demonstrated that Brca2 protein prevents
single-stranded DNA gap accumulation at replication
fork junctions and behind them by promoting Rad51
binding to replicating DNA. Without Brca2, forks with
persistent gaps are converted by Smarcal1 into
reversed forks, triggering extensive Mre11-depen-
dent nascent DNAdegradation. Stable Rad51 nucleo-
filaments, but not RPAorRad51T131Pmutant proteins,
directly prevent Mre11-dependent DNA degradation.
Mre11 inhibition instead promotes reversed fork
accumulation in the absence of Brca2. Rad51 directly
interactswith the Pol aN-terminal domain, promoting
Pol a and d binding to stalled replication forks.
This interaction likely promotes replication fork
restart and gap avoidance. These results indicate
that Brca2 and Rad51 prevent formation of abnormal
DNA replication intermediates, whose processing
by Smarcal1 and Mre11 predisposes to genome
instability.
INTRODUCTION
Maintenance of genome integrity during DNA replication relies
on the ability to respond to DNA lesions and structures impairing
replication fork progression (Flynn and Zou, 2011; Nam and
Cortez, 2011; Toledo et al., 2011). A central role in preventing
genome instability commonly associated with human cancer is
provided by the homologous recombination (HR) Brca1 andMolecular Cell 67, 867–881, Septe
This is an open access article under the CC BY-NBrca2 genes, which are often mutated in sporadic and familial
cases of cancers (Holloman, 2011; Jackson et al., 2011).
HR proteins’ roles in chromosome breakage repair are well es-
tablished (Kowalczykowski, 2015; Thorslund and West, 2007).
However, their functions in DNA replication are poorly under-
stood. This is in part due to the essential role of many HR genes
in higher eukaryotes (Jasin, 2002; Thompson and Schild, 2001).
Cell-free systems based on vertebrate Xenopus laevis egg
extract have been helpful to study essential proteins in DNA
repair, cell-cycle checkpoints, and DNA replication (Byun et al.,
2005; Hashimoto and Costanzo, 2011; Hashimoto et al., 2010,
2011; R€aschle et al., 2008; Sannino et al., 2016). Using electron
microscopy (EM) to visualize replication intermediates (RIs) iso-
lated from egg extracts, we uncovered a role for Rad51 in pre-
venting Mre11-dependent degradation of nascent DNA during
DNA replication (Hashimoto et al., 2010). Consistent with this,
Brca2, which loads Rad51 onto DNA breaks and gaps, and
Rad51 itself were shown to prevent extensive Mre11-dependent
nascent DNA degradation at stalled forks in mammalian cells
(Schlacher et al., 2011; Spies et al., 2016). Extensive DNA degra-
dationwasalso observed after loss of theRad51 stabilizing factor
BOD1L (Higgs et al., 2015). More recently, inhibition of Mre11
recruitment to stalled forksby lossof theMLL3/4 complexprotein
PTIP and PARP1 has been shown to bypass the Brca2 require-
ment for survival (Ding et al., 2016; Ray Chaudhuri et al., 2016).
A crucial role in replication fork metabolism is played by
Smarcal1 (SWI/SNF-related, matrix-associated, actin-depen-
dent regulator of chromatin, subfamily A-like1), which travels
with the elongating replication fork and is regulated by ATR
(Be´tous et al., 2012; Couch et al., 2013). In vitro, Smarcal1 pro-
motes branch migration and fork reversal on artificial DNA sub-
strates (Be´tous et al., 2012; Ciccia et al., 2012). Smarcal1 trans-
locase-dependent fork remodeling could promote reversed fork
(RVF) formation in vivo, triggering nascent DNA degradation in
Brca2-defective cells.
RVFs are induced by replication fork-stalling agents (Zell-
weger et al., 2015) under DNA damage checkpoint-deficientmber 7, 2017 ª 2017 The Author(s). Published by Elsevier Inc. 867
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Brca2 and Rad51 Function in DNA Replication
(A) The Xenopus Brca2 protein. See also Figures S1 and S2.
(B) Brca2 and Rad51 immunoprecipitations (IPs) and western blots (WBs).
(C) Brca2 and Rad51 depletion from egg extract.
(D) Chromatin binding time course with or without recombinant geminin. NS, no sperm nuclei.
(E) Brca2 and Rad51 chromatin binding normalized to histone H2B. Mean optical density ± SD of three experiments (n = 3) is shown.
(F) Chromatin binding time course in mock and Brca2-depleted extracts.
(legend continued on next page)
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conditions (Couch et al., 2013; Lopes et al., 2001). RVFs can also
form when polymerase alpha (Pol a) function is compromised in
primase mutants (Fumasoni et al., 2015) and in the absence of
Tipin-Tim1, which promotes Pol a chromatin binding (Errico
et al., 2014), suggesting the existence of a critical link between
RVFs and defects in Pol a-dependent DNA polymerization.
Here we isolated Xenopus laevis Brca2 and investigated its
molecular role at unperturbed and stalled replication forks using
egg extract. We show that Brca2 licenses Rad51 binding to repli-
cation forks. Its absence leads to the accumulation of gapped
RIs remodeled by Smarcal1 into RVFs, which act as entry
points for extensive Mre11-dependent degradation of nascent
DNA. Stable Rad51 nucleofilaments protect DNA from Mre11-
dependent degradation, whereas Rad51 interaction with Pol a
contributes to ensure continuous ungapped DNA replication.
These results uncover the molecular mechanisms underlying
Brca2-mediated replication fork protection.
RESULTS
Brca2 and Rad51 Binding to Replicating Chromatin
To understand the role of Brca2 in DNA replication, we cloned
full-length Xenopus Brca2 cDNA. Brca2 protein revealed
significant homology to human Brca2, with all major domains
conserved except for BRC5 (Figures 1A, S1, and S2). We then
raised antibodies recognizing XenopusBrca2 in egg extract (Fig-
ures S3A and S3B). In co-immunoprecipitations (coIP), Rad51
antibodies pulled down Brca2 protein. Reciprocal coIP with
anti Brca2 antibodies confirmed Rad51 binding and revealed
that only a fraction of total Rad51 in the cytoplasm was bound
to Brca2 (Figure 1B). Furthermore, depletion of more than 99%
of Brca2 reduced Rad51 levels in extract only slightly (Figure 1C).
These results suggested that Brca2 and Rad51 exist as separate
protein pools in egg cytoplasm, although a small fraction of
total Brca2 forms protein complexes with Rad51. Consistently,
depletion of Rad51 did not significantly reduce Brca2 levels in
egg extract (Figure 1C).
Under unperturbed conditions, Brca2 was loaded onto chro-
matin together with major replication factors, and its loading per-
sisted after their dissociation (Figure 1D). Notably, Brca2 loading
onto chromatin preceded and accompanied loading of Rad51,
suggesting that, similar to Rad51 (Hashimoto et al., 2010),
Brca2 binds to DNA during unperturbed replication. To verify
whether Brca2 chromatin binding was dependent on active
DNA replication, we used geminin to inhibit pre-replication com-
plex assembly (Hashimoto et al., 2010). Geminin induced signif-
icant but incomplete inhibition of Brca2 chromatin binding,
accompanied by a Rad51 chromatin loading decrease (Figures
1D and 1E). In contrast, the DNA polymerase inhibitor aphidicolin
(M-APH, 20 mM), which induces stalled forks, increased Brca2
binding to chromatin (Figure S3C). Consistent with previous re-(G) Relative incorporation of a-32P-dCTP over time in mock and Brca2-deplet
considered as 100%.
(H) DNA replication in extracts depleted as indicated and reconstituted with 50 n
nuclease (0.1 U/mL) was added at the start where indicated. Nuclei were pre-treat
mock-treated extracts at 150 min were considered as 100%. Mean values ± SD
See also Figures S1–S3.sults (Jeyasekharan et al., 2010; Reuter et al., 2014) and under
conditions in which DNA replication was inhibited, as shown by
lack of DNA-boundCdc45 because of activation of the ataxia tel-
angiectasia mutated (ATM) checkpoint (Costanzo et al., 2000),
induction of DNA double-strand breaks (DSBs) onto otherwise
DSB-free sperm chromatin also triggered prolonged Brca2 chro-
matin binding (Figure S3D). These results indicated the existence
of at least three binding modes of Brca2 to chromatin, one
dependent on DNA replication and stimulated by stalled forks,
a second independent of DNA replication, and a third induced
by DSBs.
To understand the role of Brca2 during DNA replication and
to elucidate its links with Rad51, we depleted endogenous
Brca2 from egg extract. Depletion of Brca2 did not significantly
affect chromatin binding of major replication factors. However,
it almost completely prevented Rad51 assembly onto chromatin
(Figures 1F and S3E), indicating that Brca2 was required for
active loading of Rad51 onto replicating DNA, except for a small
fraction of Rad51 associating with chromatin independently
of Brca2.
Similar to Rad51 (Hashimoto et al., 2011), Brca2 depletion did
not significantly affect chromosomal DNA replication under un-
challenged conditions (Figure 1G). However, Brca2 was required
to support restart of forks uncoupled by low amounts of aphidi-
colin (L-APH, 3 mM) and collapsed by S1 nuclease-induced DNA
breakage (Figure 1H). These conditions do not activate the
checkpoint and, in contrast to UV and methyl methanesulfonate
(MMS) treatment, do not affect replication initiation (Hashimoto
et al., 2011), allowing the analysis of Brca2 function during
ongoing DNA replication.
To verify whether Brca2’s role in fork restart was linked to
Rad51 chromatin binding stability, we cloned and expressed
the Xenopus Brca2 C terminus (Brca2c; Figures S3F and S3G),
which has been shown to stabilize Rad51 nucleofilaments
through the Rad51 binding domain (Davies and Pellegrini,
2007; Esashi et al., 2007) and promote DNA strand exchange
(Yang et al., 2002). Notably, addition of Brca2c to Brca2-
depleted extracts rescued DNA replication in the presence of
S1 nuclease and L-APH (Figure 1H) by stabilizing RAD51 binding
to chromatin (Figure S3H). On the contrary, a Rad51 binding
domain-deficient Brca2c protein (Brca2d; Figures S3F and
S3G), was unable to restore DNA replication (Figure 1H) and
Rad51 chromatin binding under similar conditions (Figure S3H).
These experiments indicated that stabilization of Rad51 binding
to chromatin was required for collapsed fork restart.
Brca2 and ssDNA Gap Formation during DNA
Replication
Because bulk incorporation of labeled nucleotide could not
detect replication impairment, we employed EM analysis of RIs
to identify more subtle defects in the absence of Brca2, usinged extracts. Counts per minute for mock-treated extracts at 150 min were
g/mL recombinant Brca2c or Brca2d proteins. L-APH (3 mM) or L-APH plus S1
ed with MMS (1% v/v) or UV (1,000 J/m2) where indicated. Counts per minute in
(n = 3) are shown.
Molecular Cell 67, 867–881, September 7, 2017 869
methods established previously (Hashimoto and Costanzo,
2011; Hashimoto et al., 2010). This approach provided snapshot
images of RIs stabilized by DNA-psoralen crosslinking prior to
their isolation. For the analysis, we considered replication bub-
bles and Y-shaped RIs, obtained by restriction digestion, which
helped to distinguish parental strands from the replicated ones
(Lopes, 2009). We observed 70- to 500-nt-long ssDNA gaps on
the replicated strands of replication fork junctions isolated from
Brca2-depleted, but not from mock-treated extracts (Figures
2A and 2B). Similar fork junction gaps were found in Rad51-
depleted extracts (Figures 2A and 2B; Hashimoto et al., 2010).
Fork junction gaps were mostly asymmetric, with only one arm
being affected (Figure 2A), and only rarely symmetric (Figure 2C).
Fork junction gaps formed in Brca2- or Rad51-depleted
extracts were not suppressed byMre11 inhibition with mirin (Fig-
ure S4A), which has been shown to inhibit Mre11 activity during
DNA replication in extracts (Hashimoto et al., 2010). This sug-
gested that fork junction gaps were due to lack of DNA polymer-
ization on one or both strands and not due to Mre11-dependent
DNA degradation. In Brca2-depleted extracts, we also observed
internal ssDNA gaps, situated at a distance from fork junctions
(Figures 2C and 2D). Internal gaps were similar to the ones
observed in Rad51-depleted extracts (Figure 2D), which were
suppressed by mirin (Hashimoto et al., 2010). Because no major
differences were observed in bulk nucleotide incorporation be-
tween mock- and Brca2-depleted extracts (Figure 1G), it was
likely that internal and fork junction gapswere subsequently filled
in by post-replicative repair.
Regulation of Nascent DNA Stability
Collectively, these observations revealed the presence of
abnormal RIs formed in the absence of Brca2 during unchal-
lenged replication. Because Brca2 protects nascent DNA from
Mre11-dependent DNA degradation at stalled forks (Schlacher
et al., 2011), we aimed to reproduce this process in Brca2-
depleted egg extract to understand whether abnormal RIs
were linked to this phenomenon. To induce fork stalling, we
supplemented egg extract with high doses of aphidicolin
(H-APH, 1.5 mM) 60 min after DNA addition (Figure 2E) to
completely inhibit DNA elongation, as shown previously (Byun
et al., 2005). Following 60 min of incubation with H-APH, large
asymmetric fork junction gaps could be observed in Y-shaped
RIs (Figure 2E) and in replication bubbles (Figure 2F, top).
H-APH-induced fork junction gaps were present in more than
70% of RIs in both mock- and Brca2-depleted extracts (Figures
S4B and S4C). Similar to spontaneous fork junction gaps found
in Brca2- or Rad51-depleted extracts (Figure S4A), mirin did
not affect H-APH-induced fork junction gap frequency and size
(Figures S4B and S4C). H-APH-induced fork gaps isolated
from mid S phase were on average z750 nt long, with some
gaps reachingz1,600 nt in length (Figure S4C).
Significantly, in Brca2-depleted extracts treated with H-APH,
we detected numerous replication bubbles in which nascent
DNA was no longer present (Figure 2F, bottom; Figure S4D).
Complete loss of nascent DNA resulting in extended regions of
ssDNA on both replicated strands could be observed only in
replication bubbles and not in Y-shaped RIs because single-
stranded DNA bubbles were resistant to restriction digestion.870 Molecular Cell 67, 867–881, September 7, 2017To verify whether the absence of nascent DNA in Brca2-
depleted extracts was due to degradation of stalled nascent
DNA, we monitored the stability of nascent DNA at stalled forks
over time. To this end, nascent DNA was labeled with a short
pulse of biotin-dUTP (deoxyuridine triphosphate) (Figure 3A),
and biotin-dUTP remaining in nascent DNA after fork stalling
was then quantified. In Brca2-depleted samples, we detected
nascent DNA loss, which was inhibited by mirin or recombinant
Brca2c, but not Brca2d proteins (Figure 3A), suggesting a
critical role for Rad51 nucleofilament stabilization in nascent
DNA protection against Mre11. Consistent with this, depletion
of Rad51 also induced extensive Mre11-dependent degradation
of nascent DNA (Figure S4E).
To verify whether formation of Rad51 nucleofilaments directly
prevented Mre11-mediated DNA degradation, we reconstituted
DNA protection in vitro using recombinant yeast Mre11, human
Rad51, and heterotrimeric replication protein A (RPA) (Fig-
ure S4F). We observed extensive Mre11-mediated degradation
of linear DNA containing a 35-nt-long 50 ssDNA overhang
(Figure 3B). As expected, no Mre11-dependent degradation
was observed on substrates containing 30 overhangs (Fig-
ure S4G). Strikingly, Rad51 pre-assembled on 50 overhangs
completely protected DNA from Mre11-mediated degradation
of the 30 end in the 30 to 50 direction (Figure 3B). Similar Rad51-
mediated protection was also observed against human Mre11
protein (Figures S4F and S4H).
Interestingly, the Rad51T131P mutant protein identified in Fan-
coni anemia (FA) patient cells, which has a reduced ability to form
stable Rad51 nucleofilaments (Wang et al., 2015), wasmuch less
efficient in protecting DNA from Mre11 nuclease at identical
concentrations (Figure 3B). To confirm the specific effect of
Rad51, we also tested ssDNA binding protein complex RPA. In
contrast to Rad51, DNA-saturating concentrations of RPA
were unable to protect DNA from Mre11-mediated degradation
(Figure 3C). Relative quantification of undegraded DNA sub-
strate at increasing protein concentrations further validated
these observations (Figure 3D). Of note, higher concentrations
of Rad51 (1,000 nM) were needed to saturate all binding sites
on the DNA substrate (Figure 3E) compared with RPA, which
could bind all available sites at 200 nM, as shown by the disap-
pearance of free DNA into a higher protein-DNA complex in a
mobility shift assay (Figure 3E). This reflected the smaller ssDNA
binding site of Rad51, which occupies 3 nt (Qiu et al., 2013)
compared with 30 nt occupied by RPA (Kim et al., 1994). Signif-
icantly, in contrast to Rad51, although RPA was able to saturate
the DNA substrate at 200 nM, it was unable to protect it from
degradation (Figure 3C). DNA protection by RPA was not seen
even at RPA concentrations ranging from 400–800 nM and
when using human Mre11 (Figures 3C and S4I). These results
were largely confirmed by the observation of similar protection
and DNA binding patterns when using substrates containing
single-stranded DNA (ssDNA) gaps (Figures S5A–S5D).
Smarcal1-Dependent Fork Reversal
Because fork junction gaps were not directly susceptible
to Mre11-dependent degradation in vivo (Figures S4A–S4C),
we looked for other abnormal RIs that could trigger extensive
nascent DNA degradation. We noticed the presence of
Brca2 Rad51Mock 
500 bp 500 bp
A
500 bp
0
20
40
60
80
100
Mock
BRCA2 
RAD51 
B
<100 100-200 200-300 300-400 
Fork junction gaps 
R
Is
 (%
)
C
0
20
40
60
80
100
Internal gaps
R
Is
 (%
)
0
1
2
>2
D
E
DNA
0            60         120  min
H-APH Mock + H-APH
RIs isolation
500 bp
500 bp
Brca2 + H-APH
500 bp
500 bp500 bp
F
Not depleted + H-APH
500 bp
Figure 2. ssDNA Gaps and Nascent DNA Degradation in the Absence of Brca2
(A) EM micrographs showing RIs isolated from mock-treated (left) and Brca2- (center) and Rad51-depleted extracts (right). Empty arrows indicate newly
replicated strands. Arrowheads indicate ssDNA gaps at fork junctions.
(B) Graph showing the distribution of fork gaps with different lengths. Bars indicate the percentage of RIs with different gap lengths in mock-treated and Brca2- or
Rad51-depleted extracts. Mean values ± SEM relative to 150 RIs counted in three experiments (n = 3) are shown.
(C) EM micrograph showing RIs isolated from Brca2-depleted extract. The full black arrow indicates an internal ssDNA fork gap.
(D) Distribution of RIs with the indicated number of internal gaps in mock-treated and Brca2- or Rad51-depleted extracts. Mean values ± SEM (n = 3) are shown.
(E) EM micrograph showing an RI isolated from an undepleted extract incubated with H-APH (1.5 mM) as shown.
(F) EM micrograph showing RIs isolated from mock-treated (top) or Brca2-depleted (bottom) extracts treated with H-APH as in (E). Insets show a higher
magnification of replication bubbles. Empty arrows indicate double-stranded DNA. Arrowheads show ssDNA.
See also Figure S4.
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Figure 3. Brca2- and Rad51-Mediated Protection from Mre11
(A) Top: experimental scheme. Bottom: relative percentage of residual biotin-dUTP in sperm nuclei quantified using a fluorescence method. The fluorescence
intensity of mock at 0 min was considered as 100%. Extracts were treated as indicated and supplemented with 100 mMmirin or recombinant Brca2c or Brca2d.
Mean values ± SD (n = 3) are shown.
(B and C) Gel showing the effect of Rad51WT and Rad51T131P (B) or RPA complex (C) pre-incubation with 50 fluorescently labeled DNA substrate (20 nM), shown in
the scheme containing phosphorothioate bonds (s), and subsequent incubation with Mre11 (30 nM). Reactions were resolved on denaturing 30% poly-
acrylamide gel.
(D) Mre11-dependent DNA degradation rates in the presence of Rad51WT, Rad51T131P, or RPA relative to the amount of substrate shown in (B), lane (), which
was considered as 100%. Mean values ± SD (n = 3) are shown.
(E) Electrophoretic mobility shift assay showing binding of Rad51WT, Rad51T131P, or RPA to the same fluorescently labeled DNA substrate (20 nM) resolved on
0.8% agarose gel.
See also Figures S4 and S5.numerous RVFs containing classical four-way junctions (Fig-
ure 4A) in RIs isolated from extracts treated with H-APH. RVF
reversed branches were 1,250 ± 200 nt long, and most of them872 Molecular Cell 67, 867–881, September 7, 2017contained long ssDNA tails (Figure 4A), suggesting that they
originated from remodeling of forks containing asymmetric
gaps (Figure 2E).
Figure 4. Smarcal1-Dependent Regulation
of RVFs
(A) EM micrograph showing RVF intermediate
isolated from extracts treated with H-APH
(1.5 mM). The arrow indicates a double-stranded
reversed branch. The arrowhead indicates
the single-stranded tail of the reversed branch.
The inset shows a high magnification of the RVF
junction.
(B) Chromatin binding of the indicated factors at
the indicated times following buffer or H-APH
supplementation. Buffer and H-APH were added
to egg extract 45 min after sperm nuclei. NS,
absence of sperm nuclei.
(C) RVF frequency in extracts treated as indicated.
Mean values ± SEM (n = 3) are shown. *,**,***p <
0.01, obtained by unpaired t test between the
marked couples.
(D) Scheme showing the assay to quantify RVFs
with ssDNA tails (STAR Methods).
(E) ELISA detection of BrdU in nascent ssDNA in
nuclei incubated in extracts treated as shown.
Where indicated, extracts were supplemented
with 5 ng/mL recombinant human Smarcal1WT or
catalytically dead Smarcal1HD. Mean intensity
values ± SD (n = 3) are shown.
See also Figure S6.To identify RVFs formation mechanism, we produced anti-
bodies against the Xenopus ortholog of the Smarcal1 translo-
case, which has been shown to promote fork reversal in vitro
on synthetic gapped substrates (Be´tous et al., 2012; Ciccia
et al., 2012). Anti-Smarcal1 antibodies could completely deplete
egg extract of the endogenous protein (Figure S6A). Depletion of
Smarcal1 did not affect the cytoplasm levels of other proteins
involved in DNA replication and resection (Figures S6A and
S6B) or DNA replication efficiency (Figure S6C). Similar to
Rad51, high levels of Smarcal1 accumulated onto chromatin
following H-APH treatment (Figure 4B). Strikingly, depletion
of Smarcal1 significantly impaired fork reversal induced by
H-APH (Figure 4C) and moderately increased H-APH-induced
fork gaps (Figures S6D and S6E). Although depletion of Rad51
also mildly impaired RVF formation, consistent with previous
findings (Zellweger et al., 2015), co-depletion of both Smarcal1
and Rad51 further suppressed RVFs, indicating that the two pro-
teins act additively to sustain RVF levels (Figure 4C).MoleculaWe then tested whether Smarcal1 was
sufficient to promote conversion of gap-
ped forks into RVFs. To this end, we
added increasing amounts of recombi-
nant Smarcal1 protein to un-depleted
egg extract treated with H-APH, which
could stimulate RVF formation (Fig-
ure S6F). Interestingly, high amounts of
Smarcal1 (25 ng/mL) induced RVFs in
which reversed branches were present
at both junctions of the replication bub-
ble (Figure S6G). This intermediate was
found only at high doses of recombinantSmarcal1 and likely reflected the higher frequency of RVFs
induced by hyperaccumulation of recombinant Smarcal1 onto
chromatin.
To quantify RVFs independently of EM analysis, we exploited
the presence of a high number of RIs with ssDNA tails in RVF
branches that could be isolated from egg extract. To this end,
we adapted an assay based on the ability of anti-bromodeoxyur-
idine (BrdU) antibodies to recognize incorporated BrdU only in
the context of ssDNA (Couch et al., 2013) and used it to quantify
RVFs because EM detected no other major source of extended
unpaired nascent ssDNA on RIs (Figure 4A). We confirmed the
existence of a linear relationship between the BrdU signal and
the number of RVFs visualized by EM because the signal was
strongly induced by H-APH and was significantly inhibited by
Smarcal1 depletion (Figure 4E). The BrdU signal strength in
Smarcal1-depleted extracts was restored by Smarcal1WT, but
not by its previously characterized catalytically inactive version
Smarcal1HD (Ciccia et al., 2012; Figure 4E), although bothr Cell 67, 867–881, September 7, 2017 873
proteins were able to bind DNA (Figure S6H). These experiments
indicated that Smarcal1 translocase activity was required to
promote the formation of RVFs. The BrdU assay also confirmed
a Rad51 and Smarcal1 additive role on RVFs observed by EM
(Figure 4E).
Fork Reversal and Nascent DNA Degradation
To determine whether RVFs were responsible for the extensive
nascent degradation observed in Brca2-depleted extracts,
we co-depleted Smarcal1 and determined nascent DNA stabil-
ity. Strikingly, Smarcal1 depletion significantly prevented the
nascent DNA degradation observed in Brca2-depleted extracts
treatedwith H-APH (Figure 5A). Supplementation of depleted ex-
tracts with recombinant Smarcal1WT, but not with Smarcal1HD
partially restored nascent DNA degradation (Figure 5A). These
experiments suggested that RVFs induced by active Smarcal1
triggered nascent DNA degradation in the absence of Rad51
bound to DNA.
To test whether Brca2 was also required for the stability of
RVFs formed by Smarcal1, we quantified RVFs induced by
H-APH in the absence of Brca2 with the method shown in Fig-
ure 4D. This experiment revealed a significant reduction in the
BrdU signal in extracts depleted of Brca2, suggesting that
RVFs were decreased in the absence of Brca2 (Figure 5B).
Significantly, the BrdU signal could be restored by addition of
mirin (Figure 5B), indicating that Brca2 was required for the
protection of RVFs from Mre11-mediated degradation but was
dispensable for RVF formation.
Importantly, Smarcal1 depletion reduced the BrdU signal in
Brca2-depleted extracts, and this inhibition was only partially
rescued by mirin (Figure 5B), consistent with a role for Smarcal1
in promoting RVF formation.
Interestingly, low levels of BrdU signal were also detected in
Brca2-depleted extracts treated with mirin in the absence of
H-APH. This signal possibly reflected spontaneous RVFs arising
in the absence of Brca2 and degraded by Mre11 (Figure S6I).
To test whether Brca2’s role in preventing RVFs degradation
was directly related to its ability to stabilize Rad51 binding
to these structures, we performed Mre11 nuclease protection
assays using synthetic RVF substrates. Rad51WT, but not
RAD51T131P protein, was able to protect synthetic RVFs from
Mre11 nuclease-mediated degradation, whereas RPA was un-
able to protect RVFs (Figures 5C–5E), despite the fact that it
could fully saturate all binding sites on synthetic RVFs in mobility
shift assays, similar to Rad51 (Figure 5F). These observations
confirmed the critical role of stable Rad51 nucleofilaments in
protecting RVFs.
Rad51-Pol a Interaction
Our results indicated that forks with persistent gaps induced by
DNA polymerization inhibition obtained with H-APH could be
converted by Smarcal1 into RVFs that were susceptible to
Mre11-dependent degradation in the absence of Rad51 bound
to DNA. However, spontaneous fork junction gaps because of
lack of DNA polymerization were also present in Rad51- or
Brca2-depleted extracts under unchallenged conditions (Figures
2A, 2B, and S4A–S4C), potentially predisposing to RVF forma-
tion (Figure S6I). Given their relevance, we tested how Rad51874 Molecular Cell 67, 867–881, September 7, 2017prevented spontaneous fork gap formation. We hypothesized
that Rad51 directly influenced replicative polymerases function.
To verify this hypothesis, we immunoprecipitated Rad51 from
egg extracts and performed western blot experiments, which
highlighted the presence of Pol a, but not Pol d, in Rad51 immu-
noprecipitates (Figure 6A). To determine the presence of a direct
interaction between Rad51 and Pol a, we produced a recombi-
nant human Pol a-primase complex, which is made of four sub-
units: the catalytic a and non-catalytic B subunits and the large
(PriL) and small subunits (PriS) of the primase (Pellegrini, 2012).
We also produced a version of the Pol a-primase complex in
which the a and B subunits lacked their N-terminal domains
(DNTD). The Pol a-primase complex, containing a His10 tag pre-
sent at the N terminus of Pri-S, was able to pull down recombi-
nant Rad51 (Figure 6B). Conversely, the version of the complex
missing the NTDswas not able to bind Rad51 protein (Figure 6B).
The NTD of the catalytic a subunit containing the first 109 amino
acidswas instead able to directly interact with Rad51 (Figure 6C).
This NTD region of the Pol a catalytic subunit contains a pattern
of negatively charged and aromatic amino acids that is highly
conserved in eukaryotes (Figure S7A) and might play a role in
binding Rad51. Importantly, this interaction was inhibited by
stoichiometric amounts of Brca2 BRC4 peptide (Figure 6D),
which prevents Rad51 polymerization (Thorslund and West,
2007). This observation suggested that the interaction with Pol
a required an oligomeric form of Rad51.
To assess the functional relevance of this interaction in the
context of replication forks, we adopted a previously established
approach based on the displacement of endogenous replication
factors by their recombinant versions, which are preferentially
incorporated into replicating DNA (Simon et al., 2016). Wild-
type (WT) and DNTD Pol a-primase complexes were added to
egg extract and shown to bind chromatin under unchallenged
and challenged conditions induced by intermediate doses of
aphidicolin (M-APH, 20 mM), which produced stalled forks but
still allowed partial DNA polymerization (Figure 6E). However,
in contrast to the WT, the DNTD Pol a-primase complex was
unable to efficiently displace endogenous Pol a bound to chro-
matin. These findings suggested that the NTD was involved in
the localization of the Pol a-primase complex to replication forks,
possibly through its interaction with Rad51 bound to forks,
although participation of other replisome components in this
process could not be excluded.
To verify the role of Rad51 in promoting stable DNA binding of
replicative polymerases, we tested the effect of Rad51 depletion
using an assay based on isolation of proteins on nascent DNA
(IPOND), in which biotin-dUTP pulses were used to label and
pull down nascent chromatin (Sirbu et al., 2013), omitting the
formaldehyde crosslinking step to isolate high-affinity nascent
DNA binding proteins present at replication forks. Depletion of
Rad51 did not affect DNA binding of replication factors such
as Cdc45 or Psf3 to stalled forks (Figure 6F) or Pol a concentra-
tion in egg extract (Figure S7B). However, it strongly inhibited
Pol a association with nascent DNA in the presence of stalled
forks induced by M-APH, and it mildly inhibited its DNA binding
under unchallenged conditions (Figures 6F and S7C). Rad51
depletion also impaired Pol d binding to stalled replication forks
(Figures 6F and S7D), although no interaction was observed with
Figure 5. RVFs and Nascent DNA Degradation
(A) Residual biotin-dUTP in nuclei replicated in extracts treated as shown. Where indicated, extracts were Smarcal1-depleted and supplemented with buffer or
5 ng/mL recombinant Smarcal1WT or Smarcal1HD proteins. The fluorescence intensity of mock at 0 min was considered as 100%.
(B) ELISA detection of BrdU in nascent ssDNA in nuclei incubated in extracts treated as shown. Mean intensity values ± SD (n = 3) are shown.
(C and D) Gel showing the effect of Rad51WT and Rad51T131P (C) or RPA (D) pre-incubation with 50 fluorescently labeled RVF, shown in the scheme, and sub-
sequent incubation with Mre11. Reactions were resolved on denaturing 30% polyacrylamide gel.
(E) Mre11-dependent DNA degradation rates in the presence of Rad51WT, Rad51T131P, or RPA relative to the amount of substrate (20 nM) shown in (C), lane (),
which was considered as 100%. Mean values ± SD (n = 3) are shown.
(F) DNA binding of Rad51 WT or RPA to the same fluorescently labeled RVF DNA substrate (20 nM) resolved on 0.8% agarose gel.
See also Figure S6.
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Figure 6. Rad51-Pol a Interaction at Stalled Forks
(A) WB of egg extract IPs using the indicated antibodies. Flowthrough (FT) and extract input (XE) are also shown.
(B) Top: Coomassie-stained gel showing pull-down experiments using Rad51 and hPol a complexes made of the Pol a catalytic subunit, B subunit, Pri-S, and
Pri-L. The Pol a catalytic and B subunits were either full-length or missing the first 333 and 148 amino acids, respectively (DNTD). His-tagged Pri-S was used for
the pull-down. Bottom: WB with anti-Rad51 antibodies of samples shown at the top.
(C) Top: Coomassie-stained gel showing pull-down experiments using Rad51 and the first 109 amino acids of Pol a (MBP-Pol a NTD) bound to amylose resin.
Bottom: WB with anti-Rad51 antibodies of the samples shown at the top.
(D) Coomassie-stained gel showing pull-down experiments using Rad51 and the first 109 amino acids of Pol a (MBP-Pol a NTD) bound to amylose resin in the
presence of increasing amounts of BRC4 peptide.
(E) Chromatin binding time course following addition of recombinant human full-length (hPol a) andNTD truncated (DNTD) complexes shown in (B) in the presence
of DMSO or M-APH. Anti-Xenopus Pol a p180 and anti-human Pol a p180 were used for the WB shown at the top and center, respectively.
(F) IPOND showing proteins bound to chromatin containing nascent DNA following biotin pull- down with streptavidin beads. Extracts were supplemented with
M-APH 45 min after nuclei addition and pulse-labeled for 10 min with biotin-dUTP as indicated. Pol a, d, and ε inputs are also shown.
(G) DNA replication in mock-treated or Rad51-depleted restarting extracts (Figure S7F). Values in mock-treated stalling extracts transferred to mock-treated
restarting extracts were considered as 100%. Mean values ± SD (n = 3) are shown. See also Figure S7.
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Pol d (Figure 6A). Because Pol d binds to and elongates the
primers synthesized by Pol a-primase, reduced Pol a levels
could indirectly prevent optimal Pol d loading onto DNA (Pelle-
grini and Costa, 2016). In contrast to Pol a/d, Pol ε binding to
replication forks in the presence of M-APH was not significantly
affected by Rad51 depletion, although it was partially inhibited
compared with un-depleted, untreated extracts (Figures 6F
and S7E). Rad51-mediated Pol aDNA binding stabilizationmight
also indirectly facilitate Pol ε association with DNA. However, this
hypothesis will need further investigation.
We then studied Rad51 involvement in DNA replication restart
at stalled forks. To this end, replication forks were stalled by
M-APH in Rad51-proficient and -deficient extracts (stalling ex-
tracts) and allowed to restart in Rad51-proficient and -deficient
extracts (restarting extracts) (Figure S7F) treated with geminin
and roscovitine, a CDK2 inhibitor, to prevent de novo origin as-
sembly and firing (Figure S7F; Errico et al., 2007; Trenz et al.,
2006). Replication could efficiently resume only in the presence
of Rad51 because depletion of Rad51 from both stalling and re-
starting extracts severely impaired fork restart (Figure 6G). These
findings confirmed that Rad51-mediated DNA binding stabiliza-
tion of replicative polymerases and nascent DNA was critical to
ensure efficient resumption of DNA replication at stalled forks.
DISCUSSION
Brca2 and Rad51 at Replication Forks
Here, using Xenopus egg extract and EM-based approaches to
analyze replication intermediates, we provided an extensive
characterization of the Brca2 and Rad51 role in DNA replication.
We showed the following: Brca2 is loaded onto chromatin during
DNA replication; Rad51 replicative function requires Brca2,
which loads most of Rad51 onto replicating chromatin; the
Brca2 C-terminal segment promotes replication fork restart
following template breakage; Brca2, like Rad51, prevents the
formation of ssDNA gaps at fork junctions and behind them un-
der unchallenged conditions; persistent fork gaps are remodeled
into RVFs by Smarcal1; Smarcal1-mediated RVFs trigger exten-
siveMre11-dependent nascent DNA degradation in the absence
of Brca2; stable Rad51 nucleofilaments directly protect DNA
from Mre11-dependent degradation; Brca2 protects RVFs
from Mre11-mediated degradation and prevents their sponta-
neous formation; and Rad51 interacts with the Pol a NTD
domain. These results provide molecular insights into the
Brca2- and Rad51-dependent fork protection mechanisms,
revealing surprising links between the HR and DNA replication
proteins.
The unexpected interaction between Rad51 and Pol a could
explain the spontaneous accumulation of fork junction gaps
in the absence of Brca2/Rad51. ssDNA gaps might occur on
DNA sequences, lesions, or structures prone to create transient
blocks to DNA polymerization (Figure 7A). Compatibly with its
ability to load Rad51 onto gapped DNA in vitro (Jensen et al.,
2010), Brca2 might promote Rad51 nucleofilament formation
ahead of stalled polymerases, facilitating their progression
through DNA segments difficult to replicate (Figure 7B).
Rad51-dependent modification of the DNA template structure
and stabilization of replicative polymerase binding to forks couldfacilitate nascent DNA synthesis (Figure 7C), avoiding gap for-
mation. Rad51 polymerization is likely required for the interaction
with Pol a because this is prevented by the BRC4 peptide. Pol a
progression on the DNA could then displace the nucleofilament
with its NTD domain, which, being negatively charged, might
weaken Rad51 binding to DNA as it progresses.
This process might happen on lagging strands given the pres-
ence of extended ssDNA regions that might fold into secondary
structures obstructing DNA polymerization, although Brca2/
Rad51 action on stalled leading strands cannot be excluded.
These findings might also explain the Rad51 requirement for
stalled fork restart (Figure 6F; Petermann et al., 2010).
In the absence of Brca2/Rad51, fork gaps transiently accumu-
late during replication (Figure 7D). DNA synthesis resuming
downstream of the stalled polymerase could partially fill the
fork junction gap, leading to the formation of internal gaps behind
forks (Figure 7E), which could be further enlarged by the action of
Mre11 in the absence of Rad51-mediated protection (Figure 7F;
Hashimoto et al., 2010). If unrepaired, fork junction gaps might
give rise to spontaneous RVFs in the absence of active Mre11.
Lower-fidelity non-replicative polymerases (McVey et al.,
2016) might participate in ssDNA gap filling (Figure 7E). This
process could contribute to developing the base substitution
signature typical of Brca2-defective cancer cells (Nik-Zainal
et al., 2016).
Smarcal1-Dependent Fork Remodeling
When left unrepaired, persistent fork junction gaps, such as the
ones induced by aphidicolin (Figure 7G), become a substrate of
Smarcal1, which promotes the formation of RVFs (Figure 7H).
Smarcal1 has been linked to RVF formation in vitro and to fork
restart in vivo (Be´tous et al., 2012; Ciccia et al., 2009, 2012).
We showed that Smarcal1 plays a major role in promoting
RVFs following replication fork arrest in vivo because RVFs are
severely decreased in the absence of Smarcal1 and stimulated
by its overexpression. Smarcal1 might be recruited by fork
gaps formed on the leading strand in the presence of RPA or
on the lagging strand when RPA molecules become limiting
(Be´tous et al., 2013).
Unfilled fork junction gaps likely play a major role in promoting
RVFs as also shown by the increased formation of RVFs caused
by the absence of a functional primase gene (Fumasoni et al.,
2015) or Pol a-stabilizing factors such as Tipin-Timeless (Errico
et al., 2014).
Similar to previous findings (Zellweger et al., 2015), Rad51
depletion decreased RVFs. Interestingly, depletion of both
Smarcal1 and Rad51 further suppressed RVFs, suggesting
that both proteins act additively to promote them. Other translo-
cases, such as FBH1, ZRANB3, HLTF, or FANCM, might also
contribute to this process (Ciccia and Symington, 2016) because
depletion of both Rad51 and Smarcal1 did not completely pre-
vent fork regression (Figures 4C and 4E).
The RVFs observed here were induced by high doses of aphi-
dicolin, which compromise ATR activation by suppressing DNA
primer synthesis (Byun et al., 2005; Van et al., 2010); lower doses
trigger robust ATR activation that prevents Smarcal1-mediated
fork remodeling (Couch et al., 2013). Because the ATR phos-
phorylation site responsible for human Smarcal1 inhibition isMolecular Cell 67, 867–881, September 7, 2017 877
Figure 7. General Model
See Discussion for an explanation.conserved, a similar mechanism is likely to regulate Xenopus
Smarcal1.
Given the inhibitory effect of ATR on Smarcal1, RVFs might
occur more frequently in genomic regions in which ATR activa-
tion is suppressed, such as centromeres (Aze et al., 2016), or
in any other situation in which the ATR checkpoint is compro-
mised (Lopes et al., 2001).878 Molecular Cell 67, 867–881, September 7, 2017Rad51-, Brca2-, and Mre11-Dependent Regulation of
Nascent DNA Stability
So far, Rad51 has only been indirectly linked to nascent DNA
protection. Here we provide biochemical evidence that Rad51
nucleofilaments directly protect ssDNA from Mre11-mediated
resection. The formation of a stable Rad51 nucleofilament is crit-
ical for this function because Rad51T131P, which cannot form
stable Rad51 nucleofilaments (Wang et al., 2015), is unable to
protect DNA. The Rad51T131P mutation was identified in FA cells
(Wang et al., 2015), suggesting that protection of nascent DNA is
important to prevent genome instability associated with FA. This
is in agreement with the role of other FA proteins at replication
forks (Schlacher et al., 2012).
Brca2-dependent Rad51 DNA binding is important to protect
RVFs from Mre11-mediated degradation (Figures 7H and 7I).
Without Brca2, RVFs formed by Smarcal1-dependent remodel-
ing of persistent fork gaps induced by aphidicolin (Figure 7J)
function as entry points for Mre11 and, possibly, other nucleases
(Figure 7K), triggering extensive degradation of both leading and
lagging strands (Figure 7L). RVF formationmightmakeDNAends
available for nuclease action by locally displacing replisome
components or disrupting local chromatin organization, which
could normally prevent nascent DNA degradation at fork gaps.
Because nascent DNA degradation is not completely sup-
pressed by Smarcal1 depletion in Brca2-depleted extracts, it
is likely that degradation at gaps behind forks continues inde-
pendent of Smarcal1. This could be due to Smarcal1-indepen-
dent RVFs and Mre11-dependent resection of internal gaps
behind forks.
Because of its limited processivity (Cejka, 2015) Mre11 might
only initiate DNA degradation at RVFs, which could then be
completed by nucleases such as ExoI, DNA2, and others in com-
bination with WRN or BLM helicases (Berti and Vindigni, 2016;
Cejka, 2015). The presence of 50 or 30 ssDNA tails of different
lengths, modified bases, or proteins bound to the end of the
reversed branch, such as Ku70/80, might influence the rate of
resection and the type of nuclease recruited. In these cases,
similar to the processing of DSBs with blocked ends (Anand
et al., 2016), endonuclease activity of Mre11 stimulated by
CtIP phosphorylated by cyclin dependent kinases (CDKs) might
be particularly useful to initiate RVF degradation.
Restoration of RVFs by suppression of Mre11 activity in
Brca2-depleted extracts indicates that Brca2 is mainly required
for protection of RVFs but dispensable for their formation.
Residual chromatin binding of Rad51 in the absence of Brca2,
although insufficient to protect DNA, might contribute to RVF
formation together with Smarcal1. Alternatively, Rad51 function
could be limited to RVF protection. Rad51 involvement in RVF
formation or protection would be compatible with the observed
Smarcal1 and Rad51 additive roles in sustaining RVF levels.
Nevertheless, Smarcal1-dependent RVFs, which can still be
observed in the absence of Rad51 (Figures 4C and 4E), are
sufficient to the trigger extensive nascent DNA degradation
that occurs when Rad51 is completely depleted (Figure S4E) or
prevented from binding DNA (Figures 3A and 5A; Schlacher
et al., 2011).
Overall, these findings are consistent with a major role for
Brca2 and Rad51 in preventing deregulated nascent DNA degra-
dation and promoting continuous and accurate DNA replication
across replication blocks. Because the Rad51 ortholog RecA in
prokaryotes protects nascent DNA from nuclease-mediated
degradation in the presence of DNA damage and promotes
loading of DNA polymerases to restart replication forks (Cour-
celle and Hanawalt, 2003), it is possible that both of these func-
tions have been conserved in eukaryotes.The characterization of the biochemical mechanisms underly-
ing Brca2/Rad51-mediated fork protection described here could
be useful to identify novel strategies to target Brca2-defective
cancer cells.
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Antibodies
Anti BrdU B44 BD Bioscience N/A
Anti-Xenopus Pol a p180 (Mouse monoclonal);
peptide antigen used: VKRLPAVTKPGH
This study Abmart: clone 13026-1-3/C199
Anti human Pol a p180 Abcam ab31777; RRID: AB_731976
Anti-Xenopus Pol d 125 kDa (Mouse Monoclonal);
peptide antigen used: SSQTKKLRGDWDDD
This study Abmart: clone 19570-1-1/C316
Anti-Xenopus Pol ε p60 (Rabbit polylconal) Shou Waga, Japan Women’s University N/A
Anti-Orc1 (Rabbit polyclonal) (Aze et al., 2016) N/A
Anti Cdc45 (Rabbit polyclonal) (Aze et al., 2016) N/A
Anti Psf3 (Rabbit polyclonal) (Hashimoto et al., 2010) N/A
Anti-Mre11 (Rabbit polyclonal) Jean Gautier, Columbia University N/A
Anti-RPA70(Rabbit polyclonal) Jean Gautier, Columbia University N/A
Anti-Rad51 (Rabbit polyclonal); peptide antigen
used: CAEAMFAINADGVGDAKD
This study N/A
Anti Xenopus Smarcal1 (Xenopus full length
protein used as antigen)
This study N/A
Anti Xenopus Brca2 (Rabbit polyclonal); peptide
antigen used: KPHIKEDQNEPESNSEYCS
This study N/A
Anti-Histone H2B Millipore clone 07-371; RRID: AB_310561
Anti-Mcm7 Santa Cruz clone sc-9966; RRID: AB_627235
Anti-Rad51 goat antibodies Santa Cruz sc6862; RRID: AB_2177096
Anti-Flag Cogentech N/A
Anti-Histone H3 Abcam clone ab1791; RRID: AB_302613
Anti-Rad51 mouse antibodies Abcam clone ab123
Bacterial and Virus Strains
WT and catalytic dead (HD, D549A E550A) mutant
Smarcal1 baculovirus vectors
(Ciccia et al., 2012) N/A
Mre11-6xHis baculovirus vector Peter Cejka, University of Zurich N/A
Biological Samples
Xenopus egg extract This study N/A
Chemicals, Peptides, and Recombinant Proteins
Xenopus Brca2 protein This study N/A
Xenopus and human Smarcal1WT and
Smarcal1HD proteins
This study N/A
Rad51 protein This study N/A
Yeast Mre11 protein This study N/A
Human Mre11-6xHis protein Peter Cejka, University of Zurich N/A
Human Polymerase a1-1462 and B1-598 subunit proteins This study N/A
Human Primase His10-tagged human
Primase PriS and PriL subunit proteins
This study N/A
RPA protein complex This study N/A
MBP tagged human Polymerase a1-109 NTD This study N/A
Geminin (Aze et al., 2016) N/A
BRC4 peptide: LLGFHTASGKKVKIAKESLDKVKNLFDE Sigma N/A
Xenopus 6xHis-TEV-SMARCAL1(FL) This study N/A
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3,5,8-Trimethylpsoralen TMP Sigma T6137
Biotin-16-dUTP Roche 11093070910
Mirin Sigma M9948
BrdU Sigma B5002
Dynabeads-ProteinA Thermo Fisher 10002D
Roscovitine Calbiochem 557360
Aphidicolin Sigma A0781
Corionic Ganadotropin Sigma CL10
Spermine Sigma S3256
Methyl Methanesulfonate (MMS) Sigma 129925
Spermidine Sigma S2626
Lysolecithin Sigma L1381
Maltose Sigma M5885
Imidazole Sigma I5513
BSA Sigma A2058
Calcium ionophore Sigma A23187
Proteinase K Sigma 3115887001
RNase A Thermo Fisher EN0531
Benzonase Sigma E1014
Critical Commercial Assays
ECL Amerhasm d RPN2232
pCRBluntIITOPO vector Thermo Fisher K28002
SuperscriptIII reverse transcriptase Thermo Fisher 18080093
QuickChange Site-Directed Mutagenesis kit Agilent Genomics 200515
SensoLyte Biotin Quantitation Kit Anaspec AS-72163
Terminal Transferase and 10X buffer NEB M0315
Phusion High-Fidelity DNA Polymerase New England Biolabs M0530
Deposited Data
Xenopus Brca2 cDNA This study GenBank: KY024483
Raw images This study http://dx.doi.org/10.17632/
xf5bvrr7gh.1
Experimental Models: Cell Lines
High Five insect cells Invitrogen B85502
Experimental Models: Organisms/Strains
Xenopus laevis females Nasco LM00535MX
Xenopus laevis males Nasco LM00715MX
Oligonucleotides
xBrca2-N1 GAGACATGGCTACATCTCAACTTGG Sigma N/A
xBrca2-C2 TCACTTTACCTGCCATTCTGCTGG Sigma N/A
xBrca2-Xho-rev(3177) CCGCTCGAGTCACTTTACCT
GCCATTCTGCTGG
Sigma N/A
Brca2-Bgl-forw(2295) GGAAGATCTACCCAAATGAC
TTCAAATCTTCGCTGTAGC
Sigma N/A
Brca2-Xho-rev(3020) CCGCTCGAGTCAGTTCTTAC
TGCACCCAGTTGTTC
Sigma N/A
Rad51T131P _for GATCTGGGTCTTCCCAGGTCGGA
ATTCTCCAAACA
Sigma N/A
Rad51T131P _rev TGTTTGGAGAATTCCGACCTGGG
AAGACCCAGATC
Sigma N/A
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Recombinant DNA
pFastbac-HTb Xenopus laevis Smarcal1 GenScript GenBank: NM_001096199
ADA400-Xenopus laevis BRCA2 This study N/A
ADA411-GST-Brca22295-3177 (Brca2c) This study N/A
ADA417-GST-Brca22295-3020 (Brca2d) This study N/A
pET11d-human RPA protein complex This study N/A
pET-11c-human Rad51 (Sigurdsson et al., 2001) N/A
pET-11c-human Rad51T131P This study N/A
pFBDM-StrepII-tagged human Polymerase
a1-1462 and B1-598 subunit
This study N/A
pFBDM-His10-tagged full length human Primase
subunits PriL and PriS
This study N/A
pMAT11-MBP- human Polymerase a1-109 NTD N/A N/A
Software and Algorithms
Prism GraphPad N/A
ImageJ Freeware N/A
Gatan Micrograph software Gatan N/A
Multi Gauge V3.2 software Fuji N/A
Other
FEI Tecnai 12 EM microscope FEI N/A
GATAN high-resolution camera Gatan N/A
Cary Eclipse fluorescence spectrophotometer Varian N/A
Bioruptor Diagenode N/A
Stratalinker equipped with 254 and 365 nm ultraviolet
light bulbs
Stratagene N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Resource and reagent requests should be directed to and will be fulfilled by the Lead Contact, Vincenzo Costanzo (vincenzo.
costanzo@ifom.eu).
EXPERIMENTAL MODEL
Eggs derived from Xenopus laevis frogs were used as experimental model system. Collection of eggs from the female frogs was per-
formed in a non-invasive way following chorionic gonadotropin (Sigma, CG10) injections. Occasional surgical procedures were per-
formed on themale frogs to harvest sperm nuclei. Experimental protocols were approved by IFOMAnimalWelfare committee and the
Italian Ministry of Health. The number of animals used was kept to a minimum and was calculated taking into account the number
eggs required to obtain the cytoplasmic extract needed for the experiments described.
The animals were kept in highly regulated and monitored conditions with room and water temperature at 19 C. Basic husbandry
requirements were provided by the IFOM Xenopus facility.
METHOD DETAILS
Protein expression and purification
6xHis-TEV-SMARCAL1(FL) from Xenopus was expressed in High Five insect cells (Invitrogen, B85502) infected with the respective
recombinant baculoviruses by Silvia Monzani and Sebastiano Pasqualato, Cogentech, Milan Proteins were isolated according to
standard procedures. Briefly, cell pellets were resuspended in lysis buffer-1 (50 mM HEPES pH7.6, 300 mM NaCl, 10% glycerol,
2 mM 2-mercaptoethanol) supplemented with protease inhibitors cocktail setIII (Calbiochem), lysed by sonication and cleared by
centrifugation. The cleared lysate was incubatedwith Talonmetal affinity resin (Clontech) for 2 hr at 4C. The resinswere thenwashed
with 30 vol. of lysis buffer-1 and the bound proteins were eluted with either 10 mM maltose (Sigma, M5885) or 250 mM imidazole
(Sigma, I5513). The eluate was further purified by SEC on Superdex-200 column (GE Healthcare) pre-equilibrated in SEC buffer
(50 mM HEPES, 150 mM NaCl, 10% glycerol). Relevant fractions were concentrated in 50 kDa molecular mass cut-off Amicon ultrae3 Molecular Cell 67, 867–881.e1–e7, September 7, 2017
centrifugal filters (Millipore). GST-Brca22295-3177 (Brca2c) and GST-Brca22295-3020 (Brca2d) were expressed in E. coli BL21(C41)
transformed with the respective expressing plasmids. Protein expression was induced by the addition of 0.2 mM IPTG at 20C
and cells were incubated overnight. Cell pellets were resuspended in lysis buffer-2 (50 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol,
1 mM EDTA and 1 mM DTT) supplemented with protease inhibitors cocktail setIII (Calbiochem), lysed by sonication and cleared by
centrifugation. The cleared lysate was incubated with glutathione Sepharose 4B (GE Healthcare) for 2 hr at 4C. The resin was then
washed with 30 vol. lysis buffer-2 and the bound proteins were eluted with 10mM reduced Glutathione in (50mMTris pH 8.0 150mM
NaCl). To cleave the GST-tag the beads were instead washedwith PreScission buffer (50mMTris pH 8.0, 150mMNaCl, 5% glycerol,
1 mM DTT, 1 mM EDTA), resuspend in an equal volume of PreScission buffer, and incubated overnight at 4C with 0.1 mg/ml
PreScission protease (produced in Cogentech, Milan). The eluate was further purified by SEC on Superdex-200 column (GE Health-
care) pre-equilibrated in SEC buffer (50 mM HEPES, 150 mM NaCl, 10% glycerol). Relevant fractions were concentrated in 30 kDa
molecular mass cut-off Amicon ultra centrifugal filters (Millipore). Double StrepII-tagged human Polymerase a (1-1462) and B
subunit (1-598) were cloned into the pFBDM vector, which was subsequently used to generate recombinant baculovirus using
the MultiBac system. The same procedure was followed to produce a baculovirus for the expression of full-length human Primase
(His10-tagged PriS and PriL). Protein expression was performed by co-infecting Sf9 insect cells at a density of 2x10
6 cells/ml
with baculoviruses encoding Pol a – B and Primase, and shaking the cells at 120 rpm for 72 hr at 27C. An N-terminally truncated
version of the complex, comprising double StrepII-tagged Polymerase a (334-1462) and B subunit (149-598), was also cloned
into pFBDM and expressed with full-length Primase in the same way. Pol a complexes were purified using Strep-Tactin Superflow
resin (IBA). The N-terminal region of human Polymerase a (1-109) was cloned into the pMAT11 vector (http://camelot.bioc.cam.ac.
uk/marko/vector/data/pmat.pdf), which encodes an N-terminal, TEV-cleavable His6-MBP tag. The protein was expressed in
Rosetta2 (DE3) cells, and purified by Ni-NTA affinity chromatography and size exclusion chromatography (25 mM Na-HEPES pH
7.2, 160 mM KCl).
Human Rad51 was overexpressed in bacterial cells from pET-11c plasmid. Rad51T131P was generated by site-directed mutagen-
esis (QuickChange, Agilent genomics) using primers listed in the Key Resources Table. The correct sequence was verified by
sequencing. All purification steps were carried out at 4C. Cells were lysed by sonication in cell-breakage buffer (50 mM Tris
pH 7.5, 10% sucrose, 10 mM EDTA, 1 mM DTT and 0.01% NP40) containing 1M KCl and protease inhibitors (2 mg/ml aprotinin,
5 mg/ml benzamidine, 10 mM chymostatin, 10 mM leupeptin and 1 mM pepstatin A). The crude extract was clarified by ultracentrifu-
gation (100 000 x g, 1 h) and the supernatant was subjected to ammonium sulfate precipitation at 0.242 g/ml. The precipitate was
resuspended in buffer K (20 mM K2HPO4, 10% glycerol, 0.5 mM EDTA) supplemented with protease inhibitors and loaded on
35 mL Q-Sepharose column. Proteins were eluted with a 350 mL gradient of 100–700 mM KCl in buffer K and then loaded onto a
5 mL hydroxyapatite (HAP, Bio-Rad) column and eluted with a 50 mL gradient of 0–600 mM KH2PO4 in buffer T (20 mM Tris-HCl
(pH 7.5), 10% glycerol, 1 mM EDTA). Fractions containing Rad51 were dialyzed for 1 hr against buffer T supplemented with
50 mM KCl and then loaded on 1 mL MonoQ column (GE Healthcare) and eluted with 10 mL gradient of 100-600 mL KCl in
buffer T. Fractions containing Rad51 were diluted in buffer T, loaded on 1 mL MonoS column (GE Healthcare) and eluted with
10 mL gradient of 100-500 mL KCl in buffer T. The peak fractions were pooled, concentrated and stored at 80C in small aliquots.
Human RPA was overexpressed in bacterial cells from pET11d plasmid and purified by the same protocol described previously for
yeast RPA (Sigurdsson et al., 2001). Briefly, soluble cell extract was loaded on 20 mL Affi-Gel Blue agarose column and the protein
was eluted with 120mL gradient of 0.5-2.5MNaSCN in buffer T. Fractions containing RPAwere dialyzed against 2 l of buffer T for 3 hr
and loaded on 5mLHAP column. RPAwas elutedwith 50mL gradient of 10-140mMKH2PO4 in buffer T. Eluate fractionswere loaded
on 1 mL MonoQ column and eluted with 10 mL gradient of 50-300 mM KCl in buffer T. Fractions containing RPA were pooled,
concentrated and stored at 80C.
Yeast Mre11 purification was performed as previously shown (Chavdarova et al., 2015). Briefly, Saccaromyces cerevisiae cells
expressing Mre11 were lysed and subjected to ammonium sulfate precipitation at 0.28 g/ml. The precipitate was dissolved in
buffer K supplemented with protease inhibitors and loaded on 7 mL Q-Sepharose column. Mre11 was eluted with a 200 mL gradient
of 100–1000 mM KCl in buffer K and loaded onto a 1 mL HAP column. Proteins were eluted with a 10 mL gradient of 0–400 mM
KH2PO4 in buffer K. Fractions containing Mre11 were loaded on a 1 mL MonoS column and eluted with a 10 mL gradient of 100–
1000 mM KCl in buffer K. Peak fractions containing Mre11 were pooled, concentrated and stored at 80C.
Human Mre11-6xHis protein was produced by overexpression in Sf9 insect cells infected by recombinant Mre11-6xHis baculovi-
rus provided by Peter Cejka (University of Zurich, Switzerland). Cell pellet was resuspended in buffer P (50 mM Tris-HCl (pH 7.5),
300 mM NaCl, 1 mM b-mercaptoethanol, 1 mM EDTA) supplemented with protease inhibitors, stirred for 30 min and clarified by
ultracentrifugation (1 hr at 100 000 x g). Soluble extract was incubated with pre-equilibrated Ni-NTA agarose resin (QIAGEN) for
1 hr with continuous mixing. Resin was washed with buffer P and bound proteins were eluted with buffer P supplemented with
250 mM imidazole. The fractions containing MRE11 were diluted in buffer T, loaded on 1 mL MonoQ column and the protein was
eluted with 10 mL of 100-1000 mM KCl in buffer T. The peak fractions were stored at 80C in small aliquots.
Egg extract and chromatin binding
Xenopus interphase egg extracts and sperm nuclei were prepared as previously described (Aze et al., 2016). Briefly, Xenopus eggs
were collected inMMRbuffer (5mMK-HEPES pH7.5, 100mMNaCl, 0.5mMKCl, 0.25mMMgSO4, 0.5mMCaCl2, 25 mMEDTA) from
chorionic gonadotropin injected female frogs. The eggs were de-jellied in 10 mM Tris pH8.0, 110mMNaCl and 5mMDTT and rinsedMolecular Cell 67, 867–881.e1–e7, September 7, 2017 e4
three times in MMR. De-jellied eggs were released in interphase in presence of 5 mMCalcium Ionophore (Sigma) for 5-6 min, washed
three times with MMR and rinsed twice in ice cold S-buffer (50 mM K-HEPES pH 7.5, 50 mM KCl, 2.5 mMMgCl2, 250 mM sucrose,
2 mM b-mercaptoethanol). Activated eggs were then packed by centrifugation at 1200 x rpm for one minute and the excess of buffer
was discarded. Eggs were crushed at 13000 x rpm for twelve minutes at 4C. The crude extract was collected and centrifuged at
70.000 x rpm for 12min at 4C in a TLA100 rotor (Beckman). The interphase extract was obtained by collecting andmixing the cleared
cytoplasmic fraction together with the nuclear membranes. For sperm nuclei preparation 4 testis were removed from 2 male frogs
and placed in petri dishes containing 10 mL EB buffer (50 mM KCl, 50 mM HEPES KOH pH7.6, 5 mM MgCl2, 2 mM DTT). Testis
were finely chopped with razor blade. The material was then transferred to 15 mL Falcon tube and spun at 2,000 x g, in a swinging
bucket rotor for 5 min at 4C. The pellet was resuspended in a total volume of 2 mL of room temperature SuNaSp buffer (0.25 M su-
crose, 75 mM NaCl, 0.5 mM spermidine, 0.15 mM spermine). To remove membranes 100 mL of 2 mg/ml lysolecithin (Sigma) were
added and incubated for 10 min at room temperature. Reaction was stopped by adding 3% BSA (Sigma). The pellet was resus-
pended again in 2 mL EB and spun at 2,000 x g for 5 min at 4C. The final pellet was resuspended in 400 mL of EB + 30% glycerol.
Sperm nuclei were tested for absence of DNA breaks with TUNEL assay as previously described (Aze et al., 2016). Briefly, 20 mL of
different sperm nuclei preparations (4000 n/ml) were incubated at 37C for 4 hr in 170 mL H2O supplementedwith 20 mL 10 x TdT buffer
(NEB), 90 U Terminal transferase (NEB) and 1 mL 32P-dCTP. Aliquots of the reaction were then precipitated with 5% TCA, 2% pyro-
phosphate solution and spotted on Whatman GF-C glass fiber filter. After ethanol washes, filters were dried and the incorporated
TCA precipitable radioactivity was counted in scintillation counter. Sperm nuclei preparations with the lowest counts were used
for all the experiments. For DNA replication assays sperm nuclei (4000 n/ml) were added to interphase egg extract treated as shown
in Figure legend. Extracts were supplemented with 32P-dCTP, incubated at 23C for the times indicated in figure legend and then
stopped with Stop buffer (1% SDS, 8 mM EDTA, 80 mM Tris-HCl pH 8 and 1 mg/ml proteinase K). The mixture was then incubated
at 50C for 2 hr. Aliquots of replication reactions precipitated with 5% TCA, 2% pyrophosphate solution and spotted on Whatman
GF-C glass fiber filter. After ethanol washes, filters were dried and the incorporated TCA precipitable radioactivity was counted in
scintillation counter and quantified as previously shown (Aze et al., 2016).
For replication fork restart sperm DNA (4000 n/ml) were incubated in 50 mL mock-treated or Rad51-depleted extracts. After nuclei
addition (60 min) extracts were supplemented with H-APH and incubated for additional 60 min. Chromatin was then isolated and
transferred to mock-treated or Rad51-depleted restarting extracts supplemented with geminin and roscovitine. DNA replication
was quantified by a-32P-dCTP DNA incorporation for 120 as described above.
For chromatin binding 40 mL egg extract containing sperm DNA were isolated from master reactions treated as shown in
Figure legends at the indicated time points. For immunoblotting, samples were diluted with 10 volumes of EB (100 mM KCl,
2.5 mM MgCl2, and 50 mM HEPES–KOH pH 7.5) containing 0.25% NP-40 and centrifuged through a 0.5 M sucrose layer at
10000 x g at 4C for 5 min. Pellets were washed once with EB and suspended in Laemmli loading buffer. Proteins were then resolved
on a SDS-PAGE and monitored by WB.
Nuclease protection
Fluorescently labeled DNA substrates were prepared by annealing as described elsewhere (Marini and Krejci, 2012). Briefly, equi-
molar amounts of the corresponding oligonucleotides were mixed in hybridizing buffer (50 mM Tris, 100 mM NaCl, and 10 mM
MgCl2), heated to 75
C for 3 min and cooled slowly to room temperature for annealing. The substrates were then purified by
HPLC using a 1 mL Mono Q column (GE Healthcare Life Sciences) and a 20 mL gradient in 10 mM Tris buffer containing 1 M
NaCl. The purity was checked on native PAGE. The corresponding fractions were then concentrated on a concentrator (Vivaspin)
and washed with buffer W (25 mM Tris and 3 mM MgCl2). The concentrations were determined using the absorbance at 260 nm
and the corresponding molar extinction coefficients. For the nuclease protection assays, DNA substrate (20 nM) was incubated
with Rad51WT, Rad51T131P or RPA in the P buffer (80 mM KCl, 10 mM Tris-HCl pH 7.5, 1 mM DTT, 10 mg/ml BSA, 2 mM MnCl2,
2 mMMgCl2 and 2mMATP) for 5 min at 37
C followed by incubation with 30-50 nM recombinant yeast or humanMre11 as indicated
in figure legend for 30min at 30C. Reactionswere deproteinized by incubation with 0.1%SDS and 500 mg/ml of proteinase K at 37C
for 5 min, heat-denatured, analyzed on 30% denaturing PAGE gels (acrylamide:bisacrylamide, 19:1) and scanned using a Fuji FLA
9000 imager. Where indicated, gels were quantified using Multi Gauge V3.2 software (Fuji).
Mobility shift
Fluorescently labeled DNA substrate (20 nM) was incubated with the amounts of Rad51WT, Rad51T131P or RPA indicated in figure
legend in the P buffer for 5 min at 37C. Reactions were resolved on 0.8% agarose gel and scanned using a Fuji FLA 9000 imager.
Electron microscopy
DNA for electron microscopy analysis was processed as previously described with some modifications (Hashimoto et al., 2010).
Briefly, for replication intermediate visualization sperm nuclei (4000 n/ml) were incubated at 23C in 200 ml egg extract for 60 min,
diluted with 400 mL of EB buffer, layered onto 800 mL EB-EDTA (EB buffer + 1 mM EDTA) + 30% (w/v) sucrose and centrifuged at
3,000xg for 10 min at 4C. Pellets were resuspended in 100 ml EB-EDTA and transferred to a 96-well plate. 4,50,8-Trimethylpsoralen
(TMP) was added at 10 mg/ml to each well. Samples were incubated on ice for 5 min in the dark and irradiated with 365 nm ultraviolet
light for 7 min on a precooled metal block. The procedure from TMP addition to irradiation with ultraviolet light was repeated threee5 Molecular Cell 67, 867–881.e1–e7, September 7, 2017
more times. Samples were then supplemented with 0.1% (w/v) SDS to lysate nuclei and treated with 100 mg/ml RNase A for 1h at
37C. For complete protein digestion, psoralen-crosslinked chromatin was incubated with proteinase K (1 mg/ml) for 2 h at 50C.
Genomic DNA was extracted by adding one volume of 1:1 (v/v) phenol–chloroform mixture, precipitated with isopropanol, washed
with 70% ethanol and processed for electron microscopy as previously shown (Hashimoto et al., 2010). Electron microscopy grid
shadowing was done with a Leica MED20, and image acquisition with an FEI Tecnai 20 EM microscope equipped with a GATAN
high-resolution camera at the IFOM electron microscopy facility. Blind analysis of EM images was performed by EM specialists.
Reagents
Aphidicolin was used at a concentration of 1.5 mM (H-APH), 20 mM (M-APH) or 3 mM (L-APH) as indicated in Figure legends. Rosco-
vitin and geminin were used as previously described (Hashimoto et al., 2010). Briefly, interphase egg extracts were supplemented
with 0.5 mM Roscovitine and 60 nM recombinant geminin to obtain restarting egg extracts, which were used to test the ability of
partially replicated chromatin to resume replication as described above. Recombinant geminin was previously described (Aze
et al., 2016). Brca2c and Brac2d were used at 50 ng/ml. Smarcal1 WT and HD protein were used at doses indicated in Figure legend.
Mirin was used at 100 mM. MMS and UV pre-treatment of sperm nuclei has been previously described (Hashimoto et al., 2010).
Briefly, sperm nuclei (40000 n/ml) were incubated with 1% (v/v) methyl methane sulfonate (MMS, Sigma) at 4C for 2 hr or irradiated
with 1,000 J/m2 ultraviolet (UV) light using a Stratalinker UV irradiator equipped with 254 nm UV light bulbs.
Nascent ssDNA detection
Nascent unpaired ssDNA in replicating egg extract was detected as previously shown with some modifications (Couch et al., 2013).
Briefly, for each sample 40 mMBrdU (Sigma) and 10 mMbiotin-16-dUTP (Roche) were added to 200 mL interphase egg extracts 10min
after addition of sperm nuclei (4000 n/ml). Extracts were mock-treated, Brca2- depleted, Rad51- or Smarcal1- depleted and supple-
mented with recombinant proteins, APH or mirin as described in Figure legends. To isolate nuclei reactions were stopped by dilution
with 900 mL ice cold EB, layered onto 500 ml of EB plus 30% (w/v) sucrose and centrifuged at 3,000 x g for 10 min at 4C. To stabilize
replication structures and prevent branch migration DNA was psoralen-crosslinked. To this end pellets were resuspended in 100 ml
EB and transferred to a 96-well plate (100 ml per well). 4,5,8-Trimethylpsoralen (TMP) was added at 10 mg/ml to each well. Samples
were incubated for 5 min at 4C in the dark and irradiated with 365 nm UV light for 7 min on a precooled metal block using a Stra-
talinker UV irradiator equipped with 365 nm light bulbs. The procedure from TMP addition to irradiation with ultraviolet light was
repeated three more times. For complete protein digestion, psoralen-crosslinked chromatin was incubated with proteinase K
(1 mg/ml) and RNase A (167 mg/ml1) for 2 h at 37C in EB. Genomic DNA was extracted with one volume of 1:1 (v/v) phenol–chloro-
form mixture, precipitated with isopropanol and partially digested with restriction enzyme StuI, which generates genomic
fragments with blunt ends in the context of AGG’CCT sequence. DNA was plated into 96 well streptavidin coated plates (Thermo
Fisher, 15500), which were incubated with mouse monoclonal antibodies against BrdU (1:500) (Anti BrdU B44 BD Bioscience) in
PBS-Triton 0.05% for 2 hr at 23C to selectively detect nascent-strand ssDNA. Plates were washed three times with PBS-Triton
0.05% and probed with HRP labeled anti mouse IgGs (Dako). After washing chemoluminescence was detected by standard ECL
using a plate reader.
Nascent DNA degradation
Sperm nuclei (4000 n/ml) were incubated in 250 ml egg extracts at 23C. Extracts were mock-treated, Smarcal1-, Brca2-, Rad51- or
Smarcal1 and Rad51 depleted as described in Figure legends. 45 min after nuclei addition extracts were supplemented with 40 mM
biotin dUTP. 15min after dUTP addition 1.5mM aphidicolin was added. 50 mL samples were taken immediately after APH addition (0)
and at 60, 120, 180 and 240 min after aphidicolin addition and supplemented with 250 mL Stop buffer. Samples were incubated with
proteinase K (1 mg/ml) and RNase A (167 mg/ml) for 2 h at 37C. Genomic DNA was extracted with phenol–chloroform, ethanol
precipitated and further separated from free nucleotides by gel filtration on G50 columns (Amersham). DNA was fragmented by
sonication, heat denatured, digested with 50 U Benzonase (Sigma) and processed for SensoLyte fluorescence biotin quantification
assay (AnaSpec) according to the manufacturer’s instructions. Fluorescence was monitored using a Cary Eclipse fluorescence
spectrophotometer.
Depletions and pull downs
To immuno-deplete Brca2, Rad51 and Smarcal1 0.5-1 mL egg extract were incubated with affinity purified IgGs (35-50 mg) at RT for
1 hr with 250 ml Dynabeads-ProteinA (Thermo Fisher, 10002D) for one to three subsequent depletion rounds lasting about 1 hr each.
For Brca2 four rounds of depletion were required. For co-immunoprecipitations beads used for depletions were extensively washed
and probed with antibodies as indicated in Figure legends.
To obtain mock-treated extract a parallel depletion was carried out using the same protocol with Dynabeads-ProteinA conjugated
with affinity purified rabbit pre-immune IgGs.
For Pol a co-precipitation experiments shown in Figure 6B saturating quantities of full-length and truncated Polymerase a com-
plexes were added to 30 mL Dynabeads-ProteinA pre-equilibrated in PD buffer (1xPBS, 5% glycerol, 0.5 mM TCEP, 0.2% Igepal).
23 1mLwashes in PD buffer supplemented with 350mMNaCl, followed by 13 1mLwash in PD buffer, were performed, after which
50 U Benzonase (EMDMillipore) was added. 400 mL 20 mMpurified Rad51 in PD buffer was added, along with BSA (Sigma Aldrich) toMolecular Cell 67, 867–881.e1–e7, September 7, 2017 e6
a final concentration of 2.5 mg/ml. Samples were incubated at 4C for 90 min with rolling, after which 4 3 1 mL washes were per-
formed, followed by elution with 100 mL PD buffer supplemented with 300 mM imidazole. Samples were analyzed by SDS-PAGE
with Coomassie blue staining. Western blotting was performed using the goat polyclonal anti-Rad51 antibody sc-6862 (Santa
Cruz Biotechnology). For experiments in Figure 6C saturating quantities of purified, DNA-free His6-MBP-Polymerase a (1-109), or
His6-MBP, were added to 100 mL Amylose resin (NEB) pre-equilibrated in PD buffer, and incubated at 4
C for 20 min. 2 3 1 mL
washes in PD buffer were performed, after which 400 mL 20 mM purified Rad51 in PD buffer was added, along with BSA (Sigma
Aldrich) to a final concentration of 2.5 mg/ml. Samples were incubated at 4C for 90 min with rolling, after which 4 3 1 mL washes
were performed, followed by elution with 100 mL PD buffer supplemented with 20 mM maltose. Samples were analyzed by SDS-
PAGE with Coomassie blue staining.
For experiments in Figure 6D 2, 5, 10, 20 and 40 mM BRC4 peptide (Sigma), whose sequence has been described in the Key
Resources Table, and 10 mM Rad51 were incubated at 37C for 15 min in PBS, 0.2% Igepal, 1mM TCEP and 5% glycerol (Pull
down buffer). Amylose resin was washed with PDB and incubated with 500 mL of 40 mM His-MBP-Pola NTD for an hour at 4C.
The resin was washed with pull down buffer and BRC4-Rad51 complex was added for another hour of incubation at 4C. The resin
was then washed and eluted in 100 mL of 50mM maltose in pull down buffer. Samples were then analyzed by SDS-PAGE with
Coomassie blue staining.
Ipond
100 ml extracts were used for each sample. Sperm nuclei were then added to reach a final concentration of 4000 nuclei/ml. 45min after
sperm nuclei addition 10 min DNA labeling pulses were carried out supplementing the extracts with 40 mM Biotin-16-dUTP (Roche)
and either 20 mM aphidicolin or DMSO as control. DNA replication was stopped by diluting 100 mL reactions with 200 mL cold EB-
EDTA buffer (50 mM HEPES-KOH pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 1 mM EDTA). Samples were homogenized by using a cut
p1000 tip and overlaid on 600 mL EB-EDTA-Sucrose buffer (EB-EDTA buffer + 30% w/v sucrose). Nuclei were collected by centrifu-
gation at 8300 x g at 4C for 10 min in a swinging-bucket rotor (TLA 100.3, Beckman). The supernatant and the dense sucrose layer
were carefully removed and the nuclear pellet resuspended with 400 mL EB-NP40 buffer (50 mM HEPES-KOH pH 7.5, 100 mM KCl,
2.5 mM MgCl2, 0.25% NP40) to lysate nuclei. Samples were then subjected twice to a 10 min sonication step (30 s ON / 40 s OFF
cycle and Max Power with a Bioruptor device, Diagenode). After the sonication step 20 mL from each sample were kept apart (5%
Input to be loaded as control for SDS-PAGE). Biotinylated DNA fragments were then pulled-down by incubation with 40 mL
Dynabeads M-280 Streptavidin (Thermo Fisher, 11205D) for 30 min at 4C. Dynabeads M-280 Streptavidin + the pull-down fractions
were then washed three times with 200 mL EB-EDTA buffer and eventually resuspended with 30 mL of 1X denaturing loading buffer.
The entire volume was eventually loaded on for SDS-PAGE and WB analysis.
Cloning
The cDNA sequences encoding Xenopus laevis Brca2 was obtained by RT-PCR, from RNA derived from Xenopus eggs with Trizol
reagent (ThermoFisher). SuperscriptIII reverse transcriptase (Thermo Fisher) and an oligo(dT)20 was used for the first strand DNA
synthesis. The full-length Brca2 sequence was amplified by PCR using a Phusion High-Fidelity DNA Polymerase (New England
Biolabs) and Brca2-N1 and Brca2-C2 reverse primers (Key Resources Table) derived from full-length oocyte cDNA next generation
sequence (unpublished data). The PCR product was cloned into pCRBluntIITOPO vector (Invitrogen) obtaining the ADA400
plasmid. Xenopus Brca2 cDNA was sequenced and the sequence was deposited in GenBank: KY024483. The sequences encoding
the C-terminal Brca2 fragments Brca22295-3177 (Brca2c) and Brca22295-3020 (Brca2d) were amplified by PCR using the primers
Brca2-Bgl-forw(2295), Brca2-Xho-rev(3177), Brca2-Xho-rev(3020) and sub-cloned in the first cassette of the dicistronic vector
pGEX6p-2rbs (GenBank: KM817768), obtaining the plasmids ADA411 (for the expression of GST-Brca22295-3177) and ADA417 (for
the expression of GST-Brca22295-3020). The cDNA encoding for Xenopus laevis Smarcal1 (GenBank: NM_001096199) cloned into
pFastbac-HTb, was obtained from GenScript. WT and catalytic dead (HD, D549A E550A) mutant SMARCAL1 baculovirus vectors
to express human Smarcal1 and expression protocols were previously described (Ciccia et al., 2012). All sequences were checked
by DNA sequencing. All primers were purchased from Sigma.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed with PRISM software and indicated in figure legend. Images shown represent typical results of
experiments repeated at least three times.
DATA AND SOFTWARE AVAILABILITY
The accession number for the Xenopus BRCA2 sequence reported in this paper is NCBI GenBank: KY024483.
Raw images have been deposited to Mendeley Data and are available at http://dx.doi.org/10.17632/xf5bvrr7gh.1.e7 Molecular Cell 67, 867–881.e1–e7, September 7, 2017
